IL10 and COVID-19: Finally, several lines of evidence suggest that the early and dramatic IL-10 elevation upon SARS-CoV-2 infection might play a detrimental pathological role in critically COVID-19 patients and IL-10 has also been proposed as a potential target for reducing COVID-19 mortality [3,39].